课题基金 / 基金详情

Vaccine and Treatment Evaluation Units: Clinical Trial Implementation and Assays to Support a Phase II Influenza Vaccine Trial

Vaccine and Treatment Evaluation Units: Clinical Trial Implementation and Assays to Support a Phase II Influenza Vaccine Trial
疫苗和治疗评估单位：支持 II 期流感疫苗试验的临床试验实施和分析
批准号：
10001666
负责人：
LISA JACKSON
金额：
$14.05万
依托单位：
KAISER FOUNDATION HEALTH PLAN OF WASHINGTON
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
项目状态：
已结题
起止时间：
2017-07-28 至 2020-12-31
来源：
https://reporter.nih.gov/project-details/10001666
关键词：
Biological AssayBirdsClinical TrialsClinical Trials UnitCommunicable DiseasesConduct Clinical TrialsContractsEvaluationIndividualInfluenza A Virus, H5N1 SubtypeInfluenza A virusPhasePopulationResourcesVaccine Clinical TrialVaccinescombatdesigninfluenza virus vaccinenamed groupprogramsvaccine trial

项目摘要

项目成果

LISA JACKSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vaccine and Treatment Evaluation Units: Clinical Operations Support
Vaccine and Treatment Evaluation Units: Clinical Operations Support
Vaccine and Treatment Evaluation Units: Clinical Operations Support
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support and Concept and Protocol Development, Implementation and Assays for a Phase I Vaccine Trial for Schistosoma
海外基金